Cargando…

Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde

Cinnamomum verum is used to make the spice cinnamon and has been used as a traditional Chinese herbal medicine for various applications. We evaluated the anticancer effect of 2-methoxycinnamaldehyde (2-MCA), a constituent of the bark of the plant, and its underlying molecular biomarkers associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Perng, Daw-Shyong, Tsai, Yu-Hsin, Cherng, Jonathan, Wang, Jeng-Shing, Chou, Kuo-Shen, Shih, Chia-Wen, Cherng, Jaw-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708962/
https://www.ncbi.nlm.nih.gov/pubmed/26792981
http://dx.doi.org/10.2147/DDDT.S93599
_version_ 1782409574344556544
author Perng, Daw-Shyong
Tsai, Yu-Hsin
Cherng, Jonathan
Wang, Jeng-Shing
Chou, Kuo-Shen
Shih, Chia-Wen
Cherng, Jaw-Ming
author_facet Perng, Daw-Shyong
Tsai, Yu-Hsin
Cherng, Jonathan
Wang, Jeng-Shing
Chou, Kuo-Shen
Shih, Chia-Wen
Cherng, Jaw-Ming
author_sort Perng, Daw-Shyong
collection PubMed
description Cinnamomum verum is used to make the spice cinnamon and has been used as a traditional Chinese herbal medicine for various applications. We evaluated the anticancer effect of 2-methoxycinnamaldehyde (2-MCA), a constituent of the bark of the plant, and its underlying molecular biomarkers associated with carcinogenesis in human hepatocellular carcinoma SK-Hep-1 cell line. The results show that 2-MCA suppressed proliferation and induced apoptosis as indicated by mitochondrial membrane potential loss, activation of caspase-3 and caspase-9, increase in the DNA content in sub-G1, and morphological characteristics of apoptosis, including blebbing of plasma membrane, nuclear condensation, fragmentation, apoptotic body formation, and long comet tail. In addition, 2-MCA also induced lysosomal vacuolation with increased volume of acidic compartments, suppressions of nuclear transcription factors NF-κB, cyclooxygenase-2, prostaglandin E(2) (PGE(2)), and both topoisomerase I and II activities in a dose-dependent manner. Further study reveals the growth-inhibitory effect of 2-MCA was also evident in a nude mice model. Taken together, the data suggest that the growth-inhibitory effect of 2-MCA against SK-Hep-1 cells is accompanied by downregulations of NF-κB-binding activity, inflammatory responses involving cyclooxygenase-2 and PGE(2), and proliferative control involving apoptosis, both topoisomerase I and II activities, together with an upregulation of lysosomal vacuolation and volume of acidic compartments. Similar effects (including all of the above-mentioned effects) were found in other tested cell lines, including human hepatocellular carcinoma Hep 3B, lung adenocarcinoma A549, squamous cell carcinoma NCI-H520, colorectal adenocarcinoma COLO 205, and T-lymphoblastic MOLT-3 (results not shown). Our data suggest that 2-MCA could be a potential agent for anticancer therapy.
format Online
Article
Text
id pubmed-4708962
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47089622016-01-20 Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde Perng, Daw-Shyong Tsai, Yu-Hsin Cherng, Jonathan Wang, Jeng-Shing Chou, Kuo-Shen Shih, Chia-Wen Cherng, Jaw-Ming Drug Des Devel Ther Original Research Cinnamomum verum is used to make the spice cinnamon and has been used as a traditional Chinese herbal medicine for various applications. We evaluated the anticancer effect of 2-methoxycinnamaldehyde (2-MCA), a constituent of the bark of the plant, and its underlying molecular biomarkers associated with carcinogenesis in human hepatocellular carcinoma SK-Hep-1 cell line. The results show that 2-MCA suppressed proliferation and induced apoptosis as indicated by mitochondrial membrane potential loss, activation of caspase-3 and caspase-9, increase in the DNA content in sub-G1, and morphological characteristics of apoptosis, including blebbing of plasma membrane, nuclear condensation, fragmentation, apoptotic body formation, and long comet tail. In addition, 2-MCA also induced lysosomal vacuolation with increased volume of acidic compartments, suppressions of nuclear transcription factors NF-κB, cyclooxygenase-2, prostaglandin E(2) (PGE(2)), and both topoisomerase I and II activities in a dose-dependent manner. Further study reveals the growth-inhibitory effect of 2-MCA was also evident in a nude mice model. Taken together, the data suggest that the growth-inhibitory effect of 2-MCA against SK-Hep-1 cells is accompanied by downregulations of NF-κB-binding activity, inflammatory responses involving cyclooxygenase-2 and PGE(2), and proliferative control involving apoptosis, both topoisomerase I and II activities, together with an upregulation of lysosomal vacuolation and volume of acidic compartments. Similar effects (including all of the above-mentioned effects) were found in other tested cell lines, including human hepatocellular carcinoma Hep 3B, lung adenocarcinoma A549, squamous cell carcinoma NCI-H520, colorectal adenocarcinoma COLO 205, and T-lymphoblastic MOLT-3 (results not shown). Our data suggest that 2-MCA could be a potential agent for anticancer therapy. Dove Medical Press 2016-01-05 /pmc/articles/PMC4708962/ /pubmed/26792981 http://dx.doi.org/10.2147/DDDT.S93599 Text en © 2016 Perng et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Perng, Daw-Shyong
Tsai, Yu-Hsin
Cherng, Jonathan
Wang, Jeng-Shing
Chou, Kuo-Shen
Shih, Chia-Wen
Cherng, Jaw-Ming
Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde
title Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde
title_full Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde
title_fullStr Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde
title_full_unstemmed Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde
title_short Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde
title_sort discovery of a novel anticancer agent with both anti-topoisomerase i and ii activities in hepatocellular carcinoma sk-hep-1 cells in vitro and in vivo: cinnamomum verum component 2-methoxycinnamaldehyde
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708962/
https://www.ncbi.nlm.nih.gov/pubmed/26792981
http://dx.doi.org/10.2147/DDDT.S93599
work_keys_str_mv AT perngdawshyong discoveryofanovelanticanceragentwithbothantitopoisomeraseiandiiactivitiesinhepatocellularcarcinomaskhep1cellsinvitroandinvivocinnamomumverumcomponent2methoxycinnamaldehyde
AT tsaiyuhsin discoveryofanovelanticanceragentwithbothantitopoisomeraseiandiiactivitiesinhepatocellularcarcinomaskhep1cellsinvitroandinvivocinnamomumverumcomponent2methoxycinnamaldehyde
AT cherngjonathan discoveryofanovelanticanceragentwithbothantitopoisomeraseiandiiactivitiesinhepatocellularcarcinomaskhep1cellsinvitroandinvivocinnamomumverumcomponent2methoxycinnamaldehyde
AT wangjengshing discoveryofanovelanticanceragentwithbothantitopoisomeraseiandiiactivitiesinhepatocellularcarcinomaskhep1cellsinvitroandinvivocinnamomumverumcomponent2methoxycinnamaldehyde
AT choukuoshen discoveryofanovelanticanceragentwithbothantitopoisomeraseiandiiactivitiesinhepatocellularcarcinomaskhep1cellsinvitroandinvivocinnamomumverumcomponent2methoxycinnamaldehyde
AT shihchiawen discoveryofanovelanticanceragentwithbothantitopoisomeraseiandiiactivitiesinhepatocellularcarcinomaskhep1cellsinvitroandinvivocinnamomumverumcomponent2methoxycinnamaldehyde
AT cherngjawming discoveryofanovelanticanceragentwithbothantitopoisomeraseiandiiactivitiesinhepatocellularcarcinomaskhep1cellsinvitroandinvivocinnamomumverumcomponent2methoxycinnamaldehyde